Back to Search
Start Over
Let the Guard Down: cAMP Activators Can Improve Immunotherapy in GBM.
- Source :
-
Cancer immunology research [Cancer Immunol Res] 2023 Oct 04; Vol. 11 (10), pp. 1300-1301. - Publication Year :
- 2023
-
Abstract
- Enhancing T-cell infiltration into glioblastoma (GBM) tumors has proven challenging yet remains crucial for improving the efficacy of immunotherapy for patients with this deadly cancer. In this issue, Qin, Huang, Li, and colleagues find that inhibiting vasculature formation driven by cancer stem cells is a promising target to enhance immunotherapy in GBM. See related article by Qin, Huang, Li, et al., p. 1351 (2).<br /> (©2023 American Association for Cancer Research.)
Details
- Language :
- English
- ISSN :
- 2326-6074
- Volume :
- 11
- Issue :
- 10
- Database :
- MEDLINE
- Journal :
- Cancer immunology research
- Publication Type :
- Academic Journal
- Accession number :
- 37702792
- Full Text :
- https://doi.org/10.1158/2326-6066.CIR-23-0667